Brian L. Swick

Reappraisal of the provisional entity primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma: A series of 10 adult and pediatric patients and review of the literature

Christian L. Baum, Brian K. Link, Vishala T. Neppalli et al. · Journal of the American Academy of Dermatology · 2011 · 74 citations

Lymphoid Neoplasia, Provisional Entity, Immunodeficiencies +8

Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C‐KIT proto‐oncogene – implications for treatment with imatinib mesylate

Brian L. Swick, Larisa Ravdel, James E. Fitzpatrick et al. · Journal of Cutaneous Pathology · 2006 · 66 citations · Full text

Pembrolizumab Therapy Triggering an Exacerbation of Preexisting Autoimmune Disease

Sneha Phadke, Ramez Ghabour, Brian L. Swick et al. · Journal of Investigative Medicine High Impact Case Reports · 2016 · 53 citations · Full text

Immunology, Pembrolizumab Therapy, Immunotherapy +17

Specific analysis of KIT and PDGFR‐alpha expression and mutational status in Merkel cell carcinoma

Brian L. Swick, Rupasree Srikantha, Kelly N. Messingham · Journal of Cutaneous Pathology · 2013 · 34 citations

Ectopic Expression of Zmiz1 Induces Cutaneous Squamous Cell Malignancies in a Mouse Model of Cancer

Laura M. Rogers, Jesse D. Riordan, Brian L. Swick et al. · Journal of Investigative Dermatology · 2013 · 32 citations · Full text

Tumor Biology, Malignant Disease, Ectopic Expression +8